| Literature DB >> 32474101 |
Baris Ozoner1, Abuzer Gungor2, Teyyup Hasanov3, Zafer Orkun Toktas3, Turker Kilic3.
Abstract
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a highly contagious life-threatening condition with unprecedented impacts for worldwide societies and health care systems. Since the first detection in China, it has spread rapidly worldwide. The increased burden has substantially affected neurosurgical practice and intensive modifications have been required in surgical scheduling, inpatient and outpatient clinics, management of emergency cases, and even in academic activities. In some systems, nonoverlapping teams have been created to minimize transmission among health care workers. In cases of a massive burden, neurosurgeons may need to be reassigned to COVID-19 wards, or teams from other regions may need to be sent to severely affected areas. Recommendations are as following. In outpatient practice, if possible, appointments should be undertaken via telemedicine. All staff assigned to the non-COVID treatment unit should be clothed in level 1 personal protective equipment. If possible, postponement is recommended for operations that do not require urgent or emergent intervention. All patients indicated for surgery must receive COVID-19 screening, including a nasopharyngeal swab and thorax computed tomography. Level 2 protection measures are appropriate during COVID-19-negative patients' operations. Operations of COVID-19-positive patients and emergency operations, in which screening cannot be obtained, should be performed after level 3 protective measures. During surgery, the use of high-speed drills and electrocautery should be reduced to minimize aerosol production. Screening is crucial in all patients because the surgical outcome is highly mortal in patients with COVID-19. All educational and academic conferences can be undertaken as virtual webinars.Entities:
Keywords: Central nervous system; Coronavirus disease 2019; Operation room; Scheduling; Severe acute respiratory syndrome coronavirus 2; Telemedicine; Viral exposure
Mesh:
Year: 2020 PMID: 32474101 PMCID: PMC7255756 DOI: 10.1016/j.wneu.2020.05.195
Source DB: PubMed Journal: World Neurosurg ISSN: 1878-8750 Impact factor: 2.104
Figure 1Severe acute respiratory syndrome coronavirus 2 virion.
Personal Protective Equipment According to Handbook of COVID-19 Prevention and Treatment
| Level 1 |
| Disposable surgical cap |
| Disposable surgical mask |
| Work uniform |
| Disposable latex gloves |
| Disposable isolation clothing |
| Level 2 |
| Disposable surgical cap |
| Medical protective mask (N95/FFP3) |
| Work uniform |
| Disposable latex gloves |
| Disposable medical protective uniform |
| Goggles |
| Level 3 |
| Disposable surgical cap |
| Medical protective mask (N95/FFP3) |
| Work uniform |
| Disposable medical protective uniform |
| Disposable latex gloves |
| Full-face respiratory protective devices or powered air-purifying respirator |
FFP, Filtering face piece.
Proposal Chart for Scheduling Formed Using Recommendations Announced by the European Association of Neurosurgical Societies, American Association of Neurological Surgeons, British Neurosurgical Society, and Turkish Neurosurgical Society
| Neuro-oncology | Neurovascular | Spine | Pediatric | Functional | Hydrocephalus | Trauma | Peripheral Nerves | ||
|---|---|---|---|---|---|---|---|---|---|
| Low acuity surgery | Asymptomatic benign intracranial tumors (e.g., meningioma, schwannoma, pituitary adenoma) | Microvascular decompression of cranial nerves | Degenerative spinal disease (lumbar stenosis, spinal deformity) without neurologic deficits | Deep brain stimulation | Carpal tunnel release | Postpone surgery | |||
| Intermediate acuity surgery | Symptomatic benign intracranial tumors | Unruptured aneurysm Arteriovenous malformation | Craniosynostosis | Deep brain stimulation for progressive parkinsonism | Normal-pressure hydrocephalus | Postpone surgery if possible | |||
| High acuity surgery | Malignant primary tumors | Subarachnoid hemorrhage | Progressive cervical and thoracic myelopathy | Myelomeningocele | Battery depletion in deep brain stimulation patients | Progressive increase of intracranial pressure with hydrocephalus | Acute subdural hematoma | Malignant peripheral nerve tumors | Urgency |
Summary of COVID-19 Pandemic Measures
| Academic activities |
| All in-person conferences should be cancelled |
| All conferences can occur via video teleconferences |
| Outpatient department |
| Appointments switched to telemedicine |
| Actual visits reserved for selected patients, such as wound control |
| Use absorbable sutures |
| Use level 1 PPE in non-COVID-19 facilities |
| Single companion for pediatric or nonambulatory patients |
| Lone visits for ambulatory individuals |
| Social distancing measures during appointments |
| Operation theater staff prevention |
| COVID-19 screening for all patients (nasopharyngeal swab, and thorax computed tomography scan) |
| COVID-19–negative operations: level 2 PPE |
| COVID-19–positive or emergency operations: level 3 PPE |
| Routine training about wearing and removing PPE |
| General considerations for COVID-19–positive operation |
| Clear the route during transfers |
| Separate negative pressure operating room with independent access |
| Separate mechanical ventilator |
| Endotracheal intubation with video-laryngoscope |
| Level 3 PPE is obligatory for all operating room staff |
| Powered air-purifying respirators for the surgical team |
| Minimum operating room staff number |
| Procedures performed by experienced neurosurgeons |
| Surgical considerations for COVID-19–positive operation |
| Reduced use of high-speed drills |
| More meticulous irrigation and reduction of drill speed |
| Increased use of traditional hand drills and rongeurs |
| Avoid breaching frontal or ethmoidal sinuses |
| Reduced use of electrocautery with reduced power setting |
PPE, Personal protective equipment.